FI883930L - Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi - Google Patents
Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI883930L FI883930L FI883930A FI883930A FI883930L FI 883930 L FI883930 L FI 883930L FI 883930 A FI883930 A FI 883930A FI 883930 A FI883930 A FI 883930A FI 883930 L FI883930 L FI 883930L
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- benzimidazole derivatives
- analogous process
- useful benzimidazole
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3728695 | 1987-08-25 | ||
DE19873728695 DE3728695A1 (de) | 1987-08-25 | 1987-08-25 | Neue benzimidazol-derivate |
Publications (4)
Publication Number | Publication Date |
---|---|
FI883930A0 FI883930A0 (fi) | 1988-08-25 |
FI883930L true FI883930L (fi) | 1989-02-26 |
FI99013B FI99013B (fi) | 1997-06-13 |
FI99013C FI99013C (fi) | 1997-09-25 |
Family
ID=6334659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI883930A FI99013C (fi) | 1987-08-25 | 1988-08-25 | Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi |
Country Status (17)
Country | Link |
---|---|
US (1) | US4925854A (fi) |
EP (1) | EP0304789B1 (fi) |
JP (1) | JP2818170B2 (fi) |
AT (1) | ATE86982T1 (fi) |
AU (1) | AU615939B2 (fi) |
CA (1) | CA1330440C (fi) |
DD (1) | DD274215A5 (fi) |
DE (2) | DE3728695A1 (fi) |
DK (1) | DK169701B1 (fi) |
ES (1) | ES2054752T3 (fi) |
FI (1) | FI99013C (fi) |
HU (1) | HU201746B (fi) |
IE (1) | IE63283B1 (fi) |
IL (1) | IL87561A (fi) |
NO (1) | NO170852C (fi) |
PT (1) | PT88326B (fi) |
ZA (1) | ZA886336B (fi) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
US5371102A (en) * | 1992-03-11 | 1994-12-06 | University Of Hawaii | Compositions and methods of inhibiting thyroid activity |
ZA953311B (en) | 1994-04-29 | 1996-10-24 | Lilly Co Eli | Non-peptidyl tachykinin receptor antagonists |
US5565454A (en) * | 1995-05-31 | 1996-10-15 | Ergo Science, Incorporated | Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions |
TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
GB9526511D0 (en) * | 1995-12-23 | 1996-02-28 | Astra Pharma Prod | Pharmaceutically active compounds |
AU2003282510A1 (en) * | 2002-10-11 | 2004-05-04 | Bristol-Myers Squibb Company | Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
AU2011383263B2 (en) | 2011-12-16 | 2014-09-04 | Colgate-Palmolive Company | Color changing compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3813409A (en) * | 1972-07-31 | 1974-05-28 | Squibb & Sons Inc | Benzimidazolinone compounds |
DE3042481A1 (de) * | 1980-11-11 | 1982-06-16 | A. Nattermann & Cie GmbH, 5000 Köln | (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US4367337A (en) * | 1981-01-05 | 1983-01-04 | The Sherwin-Williams Company | Process for conversion of benzimidazolones to benzotriazoles |
AU592765B2 (en) * | 1984-08-15 | 1990-01-25 | Schering Aktiengesellschaft | New dopamine derivatives, process for their production, and their use as medicinal products |
US4554287A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones |
-
1987
- 1987-08-25 DE DE19873728695 patent/DE3728695A1/de not_active Withdrawn
-
1988
- 1988-08-17 DE DE8888113339T patent/DE3879322D1/de not_active Expired - Lifetime
- 1988-08-17 ES ES88113339T patent/ES2054752T3/es not_active Expired - Lifetime
- 1988-08-17 EP EP88113339A patent/EP0304789B1/de not_active Expired - Lifetime
- 1988-08-17 AT AT88113339T patent/ATE86982T1/de active
- 1988-08-22 IE IE255288A patent/IE63283B1/en not_active IP Right Cessation
- 1988-08-23 DD DD88319141A patent/DD274215A5/de not_active IP Right Cessation
- 1988-08-23 JP JP63207486A patent/JP2818170B2/ja not_active Expired - Lifetime
- 1988-08-24 NO NO883776A patent/NO170852C/no unknown
- 1988-08-24 CA CA000575617A patent/CA1330440C/en not_active Expired - Fee Related
- 1988-08-24 PT PT88326A patent/PT88326B/pt not_active IP Right Cessation
- 1988-08-24 HU HU884447A patent/HU201746B/hu not_active IP Right Cessation
- 1988-08-25 US US07/236,383 patent/US4925854A/en not_active Expired - Fee Related
- 1988-08-25 IL IL87561A patent/IL87561A/xx not_active IP Right Cessation
- 1988-08-25 FI FI883930A patent/FI99013C/fi not_active IP Right Cessation
- 1988-08-25 DK DK474288A patent/DK169701B1/da not_active IP Right Cessation
- 1988-08-25 AU AU21498/88A patent/AU615939B2/en not_active Ceased
- 1988-08-25 ZA ZA886336A patent/ZA886336B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE86982T1 (de) | 1993-04-15 |
NO170852B (no) | 1992-09-07 |
CA1330440C (en) | 1994-06-28 |
NO883776D0 (no) | 1988-08-24 |
EP0304789A2 (de) | 1989-03-01 |
PT88326B (pt) | 1995-03-31 |
JP2818170B2 (ja) | 1998-10-30 |
NO883776L (no) | 1989-02-27 |
DD274215A5 (de) | 1989-12-13 |
US4925854A (en) | 1990-05-15 |
IE63283B1 (en) | 1995-04-05 |
IL87561A (en) | 1993-02-21 |
HU201746B (en) | 1990-12-28 |
DK474288A (da) | 1989-02-26 |
PT88326A (pt) | 1989-06-30 |
JPS6468359A (en) | 1989-03-14 |
HUT49589A (en) | 1989-10-30 |
IE882552L (en) | 1989-02-25 |
FI883930A0 (fi) | 1988-08-25 |
AU615939B2 (en) | 1991-10-17 |
DK474288D0 (da) | 1988-08-25 |
IL87561A0 (en) | 1989-01-31 |
ES2054752T3 (es) | 1994-08-16 |
DE3879322D1 (de) | 1993-04-22 |
AU2149888A (en) | 1989-03-02 |
DK169701B1 (da) | 1995-01-16 |
FI99013C (fi) | 1997-09-25 |
ZA886336B (en) | 1989-04-26 |
EP0304789B1 (de) | 1993-03-17 |
DE3728695A1 (de) | 1989-03-09 |
EP0304789A3 (en) | 1989-10-04 |
FI99013B (fi) | 1997-06-13 |
NO170852C (no) | 1992-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI875660L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi | |
FI873205A0 (fi) | Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
FI92934B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi | |
FI881180L (fi) | Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi | |
FI883050L (fi) | Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi | |
FI883064A (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
FI880941A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi | |
FI90346C (fi) | Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi | |
FI914905L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi | |
FI882638L (fi) | Menetelmä terapeuttisesti käyttökelpoisten booriaminohappojohdannaisten valmistamiseksi | |
FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
FI874459A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi | |
FI880869A (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
FI921473L (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi | |
FI906408L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi | |
FI93215C (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi | |
FI883997L (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi | |
FI884910A (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi | |
FI880467A (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
FI884471A0 (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
FI104075B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi | |
FI893003L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
FI924642L (fi) | Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi | |
FI882002L (fi) | Menetelmä terapeuttisesti aktiivisten fenyylipiperidiinijohdannaisten valmistamiseksi | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: SCHERING AKTIENGESELLSCHAFT |